Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Cancer”

9,990 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 9,990 results

Not applicableUnknownNCT05414162
What this trial is testing

Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Who this might be right for
DLBCLMultiple MyelomaCytokine Release Syndrome+6 more
University Hospital, Bonn 60
Testing effectiveness (Phase 2)Ended earlyNCT01832727
What this trial is testing

Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 65
Testing effectiveness (Phase 2)WithdrawnNCT01933061
What this trial is testing

Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Celgene Corporation
Testing effectiveness (Phase 2)Looking for participantsNCT04973605
What this trial is testing

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
BeOne Medicines 246
Early research (Phase 1)Study completedNCT00400556
What this trial is testing

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Who this might be right for
Multiple MyelomaCutaneous Lymphoma
Peter MacCallum Cancer Centre, Australia 6
Early research (Phase 1)Study completedNCT00687622
What this trial is testing

Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

Who this might be right for
Solid Tumours
GlaxoSmithKline 206
Testing effectiveness (Phase 2)Study completedNCT00881751
What this trial is testing

Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
Medical University of South Carolina 95
Testing effectiveness (Phase 2)UnknownNCT04033302
What this trial is testing

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Testing effectiveness (Phase 2)Study completedNCT00339196
What this trial is testing

5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS

Who this might be right for
Acute Myelogenous Leukaemia (AML)Myelodysplastic Syndrome (MDS)
Assistance Publique - Hôpitaux de Paris 25
Large-scale testing (Phase 3)Ended earlyNCT01108705
What this trial is testing

Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment

Who this might be right for
Carcinoma, Hepatocellular
Bristol-Myers Squibb 87
Not applicableStudy completedNCT00607529
What this trial is testing

Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center 99
Early research (Phase 1)Study completedNCT00083460
What this trial is testing

Study of Combination PS-341 and Thalidomide in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 86
Not applicableStudy completedNCT04076696
What this trial is testing

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

Who this might be right for
Pulmonary Nodule, SolitaryPulmonary Nodule, Multiple
UNC Lineberger Comprehensive Cancer Center 38
Large-scale testing (Phase 3)Study completedNCT00117286
What this trial is testing

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 57
Not applicableLooking for participantsNCT07327970
What this trial is testing

Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer

Who this might be right for
Breast Cancer
Young-Joon Kang 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05083169
What this trial is testing

Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 587
Testing effectiveness (Phase 2)WithdrawnNCT06881823
What this trial is testing

Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals
Not applicableNo Longer AvailableNCT02624570
What this trial is testing

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML) WithFLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Not applicableUnknownNCT04391283
What this trial is testing

First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting

Who this might be right for
Carcinoma, Non-Small-Cell Lung
First Affiliated Hospital of Zhejiang University 500
Load More Results